Chinese Journal of Pharmacovigilance ›› 2019, Vol. 16 ›› Issue (5): 318-318.
Previous Articles Next Articles
QI Chendong, CHENG Jie, ZHU Yujun, FAN Guorong*
Received:
2019-01-16
Revised:
2019-06-11
Online:
2019-05-20
Published:
2019-06-11
CLC Number:
QI Chendong, CHENG Jie, ZHU Yujun, FAN Guorong. One Case of Anaphylactic Shock Induced by Pethidine Hydrochloride Injection[J]. Chinese Journal of Pharmacovigilance, 2019, 16(5): 318-318.
[1] 詹可顺. 阿片类镇痛药的临床合理用药分析[J]. 中国医药指南, 2010, 8(12):102-103. [2] 左笑丛. 癌症患者阿片类止痛药的合理应用及不良反应对策[J]. 中国药物警戒, 2008, 5(1):41-44. [3] Flacke J W, Flacke W E, Bloor B C, et al.Histamine release by four narcotics: a double-blind study in humans[J]. Anesth Analg,1987,66(8):723. [4] Baldo B A, Pham N H.Histamine-releasing and allergenic properties of opioid analgesic drugs: resolving the two[J]. Anaesth Intensive Care,2012, 40(2):216. [5] 伏晓, 姚恩霞, 徐前进. 阿片类药物不良反应防治对策[J]. 中华全科医学, 2008, 6(7):752. [6] 魏绪庆,田素杰,石宝瑞. 麻醉治疗学[M]. 北京:科学技术文献出版社,1998:795. [7] 刘小云, 王燕, 刘倩,等. 盐酸哌替啶的罕见不良反应[J]. 中国药业, 2007, 16(19):61. [8] 孙增勤,沈七襄,石翊飒.麻醉失误与防范[M]. 北京:科学技术文献出版社,1998:25. [9] 杨国帅, 马世斌. 786例药源性过敏性休克分析[J]. 中国药物警戒, 2007,17(5):289-292. [10] 蹇令秋. 哌替啶中毒致呼吸心脏骤停抢救成功1例[J]. 中国煤炭工业医学杂志,2008,11(1):115. [11] 胡正碧, 李智. 术后用哌替啶镇痛致过敏性休克抢救成功1例[J]. 重庆医学, 2001, 30(5):405. |
[1] | SUN Qiyue, ZHAO Ronghua, GUO Shanshan, BAO Lei, GENG Zihan, LI Shuran, XU Yingli, ZHANG Jingsheng, CUI Xiaolan, SUN Jing. Multiple pharmacological effects of Lingyang Ganmao Oral Liquid [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 127-131. |
[2] | ZHAO Ronghua, SUN Jing, BAO Lei, GENG Zihan, TAO Xiali, ZHANG Jingsheng, PANG Bo, XU Yingli, CAO Shan, LI Shuran, GUO Shanshan, WANG Daohan, CUI Xiaolan. Mechanisms of Gegen Tang granules against viral pneumonia in mice based on immune regulation [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 132-136. |
[3] | BAO Lei, GENG Zihan, LI Shuran, JI Zuen, ZHAO Ronghua, SUN Jing, GUO Shanshan, CUI Xiaolan. The critical role of TRP channels in the progression of viral pneumonia [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 137-140. |
[4] | JIA Jinsheng, LIU Hongliang, WANG Qing, HOU Yongfang, LI Xinling. Evaluation of the relevance of adverse drug reaction based on ERNIE-DPCNN [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 163-166. |
[5] | LI Jiaxin, LIU Huimin, QIAN Wenxiu, MA Ning, SONG Lili, LI Yubo. Nephrotoxic effects and usage of traditional Chinese medicines based on the Traditional Chinese Medicine Systems Toxicology Database [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 173-180. |
[6] | FAN Kaikai, WANG Cong, LIU Hongfeng, WANG Xiyong. Effects of clinical pharmacist interventions on usage of alanyl-glutamine injections in a hospital [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 181-184. |
[7] | ZHANG Jian, FANG Huihua. Applicability of evaluation standards for use of traditional Chinese medicine injections for promoting blood circulation and removing blood stasis [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 185-189. |
[8] | WANG Shan, XIE Bo, LIU Huimin, LI Zhihao. Adverse event signals for celecoxib based on FAERS database [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 190-194. |
[9] | LI Yingfen, HAN Lei. Analysis of 319 cases of adverse drug reaction induced by cerebroprotein hydrolysate for injection [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 195-198. |
[10] | XU Weijia, PENG Qi, HUANG Haiyu, ZHANG Leijiao, XIAO Hua, WU Xue. 285 cases of adverse drug reaction related to new antineoplastic drugs [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 199-203. |
[11] | GUO Qinghua, PENG Xiaoxiao, ZHU Ping, LIU Xilin, YANG Yinghua, CHEN Zhihai. One case of multiple organ dysfunction syndrome caused by amlodipine overdose [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 204-207. |
[12] | FANG Meilin, ZHENG Huimin, WANG Cunze, WANG Ling, RUAN Junshan. One case of generalized myalgia caused by oxaliplatin [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 208-210. |
[13] | LI Na, GUO Jun, GUO Wenjia, LYU Yinyin, LI Caihong, MU Xiangdong. One case of delayed skin allergic reaction caused by asthma treated with omalizumab injection [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 211-212. |
[14] | CAO Guiping, DENG Linlin, ZHU Ganhong, LU Ying, MA Shuang, CHEN Linlin, Liu Lili. One case of severe liver injury caused by Tianma Shouwu tablets [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 216-218. |
[15] | ZHU Ying, SHEN Lu, LI Lan, WU Jianmin, GAO Xiaojie. Adverse reaction monitoring of toothpaste in China under the new regulatory system [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 219-222. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||